Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study

by Adamo, Vincenzo, Ricciardi, Giuseppina Rosaria Rita, Giuffrida, Dario, Scandurra, Giuseppa, Russo, Antonio, Blasi, Livio, Spadaro, Pietro, Iacono, Carmelo, Soto Parra, Hector J., Savarino, Antonino, Ferraú, Francesco, Zerilli, Filippo, Verderame, Francesco, Butera, Alfredo, Santangelo, Carlo, Franchina, Veronica, Caruso, Michele
Published in Ther Adv Med Oncol (2019)

Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists

by Blasi, Livio, Bordonaro, Roberto, Borsellino, Nicolò, Butera, Alfredo, Caruso, Michele, Cordio, Stefano, Liborio, Di Cristina, Ferraù, Francesco, Giuffrida, Dario, Parra, Hector Soto, Spada, Massimiliano, Tralongo, Paolo, Valenza, Roberto, Verderame, Francesco, Vitello, Stefano, Zerilli, Filippo, Piazza, Dario, Firenze, Alberto, Gebbia, Vittorio
Published in Ecancermedicalscience (2020)